Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesAplastic and other anemias and other bone marrow failure syndromesICD-10-CM d60-acquired-pure-red-cell-aplasia
    Ask Trek AI about this page

    ICD-10-CM Code For Acquired Pure Red Cell Aplasia Erythroblastopenia: Group Overview

    The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group D60 includes acquired pure red cell aplasia and erythroblastopenia diagnoses that cover isolated failure of red blood cell production in the bone marrow. These ICD-10-CM diagnosis codes are used to document clinical scenarios involving profound anemia due to absent or severely reduced erythroid precursors, capturing disease severity and bone marrow involvement. Accurate coding within the ICD-10-CM D60 group supports proper claim adjudication, complete clinical documentation, and appropriate reimbursement.

    Customize your policy alerts

    Sign up for ICD-10-CM Code For Acquired Pure Red Cell Aplasia Erythroblastopenia: Group Overview policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    ICD-10-CM D60: Acquired Pure Red Cell Aplasia [Erythroblastopenia] Overview

    This group represents acquired pure red cell aplasia, a bone marrow failure syndrome targeting red blood cell precursors leading to anemia without significant leukocyte or platelet involvement. It affects the hematopoietic system and may be associated with autoimmune disorders, medications, or thymoma. Accurate coding matters because it ensures correct clinical documentation and supports appropriate claim processing and reimbursement for treatments.

    Table of contents

    Progress1 / 5

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    When to Use

    Use a code from this group when documentation indicates acquired pure red cell aplasia or erythroblastopenia with suppression of erythroid precursors and resultant anemia. Select the specific code when clinical records specify the cause or associated conditions such as drug-induced aplasia or thymoma, as documented by the treating clinician.

    ICD-10-CM Codes

    4 rows

    ICD-10-CM CodeDescription
    D60.0Chronic acquired pure red cell aplasia
    D60.1Transient acquired pure red cell aplasia
    D60.8Other acquired pure red cell aplasias
    D60.9Acquired pure red cell aplasia, unspecified

    DRG Codes

    3 rows

    DRG CodeDescription
    808Major Hematological and Immunological Diagnoses Except Sickle Cell Crisis and Coagulation Disorders with MCC
    809Major Hematological and Immunological Diagnoses Except Sickle Cell Crisis and Coagulation Disorders with CC
    810Major Hematological and Immunological Diagnoses Except Sickle Cell Crisis and Coagulation Disorders without CC/MCC

    Related Codes

    D61-OTHER-APLASTIC-ANEMIAS

    ICD-10-CM Code For Other Aplastic Anemias And Other Bone Marrow Failure Syndromes: Group Overview

    D62-ACUTE-POSTHEMORRHAGIC-ANEMIA

    ICD-10-CM Code For Acute Posthemorrhagic Anemia: Group Overview

    D63-ANEMIA-IN-CHRONIC-DISEASES

    ICD-10-CM Code For Anemia In Chronic Diseases Classified Elsewhere: Group Overview

    D64-OTHER-ANEMIAS

    ICD-10-CM Code For Other Anemias: Group Overview

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.